Ingevity Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.2% | -2.1% | -11.3% | -2.8% | -8.5% | +1.7% | -8.7% | -2.3% | -10.0% | -0.1% | -6.8% | |
| – | -10.3% | +1.6% | +2.5% | -7.1% | -22.6% | +7.5% | +1.1% | -2.6% | -13.0% | +28.1% | -6.5% | |
| – | +13.5% | -7.7% | +21.4% | +26.2% | -49.8% | +5.1% | +7.6% | +8.5% | -6.4% | +22.2% | +2.1% | |
| – | +13.5% | -7.7% | +21.4% | +26.2% | -49.8% | +5.1% | +7.6% | +8.5% | -6.4% | +22.2% | +2.1% | |
| – | -2.6% | -9.3% | +11.6% | -11.0% | -14.3% | +0.6% | +18.1% | -13.1% | -6.1% | -4.2% | +3.0% | |
| – | -20.1% | +5.4% | -7.2% | -13.6% | -24.9% | +25.3% | -10.2% | -12.1% | -4.0% | +9.5% | -24.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.4% | -0.3% | -66.3% | +5.6% | -6.3% | +3.1% | -97.6% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +2.6% | -21.4% | -2.3% | +1.0% | +8.5% | -14.5% | +0.8% | -4.1% | -19.5% | -22.0% | -18.3% | |
| – | -2.7% | +0.3% | -0.4% | +0.3% | -8.5% | -0.3% | -3.5% | -3.5% | -4.4% | -0.6% | -7.5% | |
| – | +18.9% | -3.1% | +1.7% | +0.8% | -26.8% | +0.2% | +48.6% | +4.7% | -17.1% | +20.0% | -17.5% | |
| – | +381.8% | +0.4% | +17.4% | -2.1% | -34.2% | -2.6% | +43.7% | +2.4% | -47.5% | +129.5% | +15.5% | |
| – | -19.7% | -3.3% | -7.0% | -32.2% | -2.1% | +14.6% | -6.3% | -0.6% | -8.8% | -7.6% | +3.5% | |
| – | -5.9% | +1.9% | -0.5% | -0.2% | -4.1% | -0.5% | -7.3% | -6.2% | +0.3% | -6.8% | -2.4% | |
| – | -12.1% | -10.0% | -49.9% | -24.7% | -9.0% | +20.2% | -48.6% | +14.4% | -78.5% | +31.0% | +20.6% | |
| – | -10.4% | -5.6% | -30.0% | -16.2% | +3.0% | +3.6% | -24.7% | +9.8% | -17.3% | +14.8% | +7.6% | |
| – | -0.5% | +0.2% | +0.2% | +0.0% | +0.7% | +0.2% | -0.7% | +1.6% | -3.5% | +0.8% | -1.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.